Total Health

 

Total Health is the largest provider of free cancer care resources for people who are treating or living with cancer. Our programs arm cancer care teams with the latest research and strategies to improve patient outcomes.

For more info visit our website at Total Health.

 

2020 Best of Breast
19:20

2020 Best of Breast

Case of 54 y/o F With Metastatic Breast Cancer: Eligibility for Genetic Testing & Data on Olaparib and Talazoparib for Pts With Germline BRCA Mutations

FEATURING Kristina Mirabeau-Beale, Bolivar Arboleda, Jennifer Klemp, Monica Yepes, Jane Meisel, Miguel A. Medina, Wendy K. Chung
  • 125 views
  • March 20, 2020
  • 1
11:26

2020 Best of Breast

Case of 54 y/o F With Metastatic Breast Cancer: Altering Treatment Plan Bc the Somatic and Germline Testing Was Not Concordant? & Why Is Important to Know Both the Germline and Somatic Results?

FEATURING Kristina Mirabeau-Beale, Bolivar Arboleda, Jennifer Klemp, Monica Yepes, Jane Meisel, Miguel A. Medina, Wendy K. Chung
  • 90 views
  • March 20, 2020
  • 1
23:49

2020 Best of Breast

Case of 53 y/o Post-menopausal F With TNBC Who Undergoes Genetic Testing: RAD51 Mutation, Incorporating Platinum in the Neoadjuvant Setting & PARPi in the Metastatic and Curative Setting

FEATURING Kristina Mirabeau-Beale, Bolivar Arboleda, Jennifer Klemp, Monica Yepes, Jane Meisel, Miguel A. Medina, Wendy K. Chung
  • 370 views
  • March 20, 2020
  • 5
19:58

2020 Best of Breast

Case of 53 y/o Post-menopausal F With TNBC and Mutations in RAD51: Cascade Testing & Recommended Management of BRCA 1/2 Mutation

FEATURING Kristina Mirabeau-Beale, Bolivar Arboleda, Jennifer Klemp, Monica Yepes, Jane Meisel, Miguel A. Medina, Wendy K. Chung
  • 80 views
  • March 20, 2020
20:08

2020 Best of Breast

Treatment of 45 y/o With CHEK2 Mutated Breast Cancer: Screening Guidelines for High Risk Pts

FEATURING Kristina Mirabeau-Beale, Bolivar Arboleda, Jennifer Klemp, Monica Yepes, Jane Meisel, Miguel A. Medina, Wendy K. Chung
  • 177 views
  • March 20, 2020
  • 2
13:53

2020 Best of Breast

Decision Making in Early Stage BC - Case of 36 y/o Pre-Menopausal Woman: Is There a Role for Breast MRI? Considering Neoadjuvant Therapy? Using Genomic Test to Determine Benefit of Chemo?

FEATURING Kevin Kalinsky
  • 100 views
  • March 2, 2020
  • 1
12:13

2020 Best of Breast

Decision Making in Early Stage Breast Cancer - Case of 36 y/o Pre-Menopausal Woman: Using Anthracycline Chemo? Data from ABC Trials - The TaxAC Regimens Improved IDFS

FEATURING Kevin Kalinsky
  • 53 views
  • March 2, 2020
29:23

2020 Best of Breast

Decision Making in Early Stage Breast Cancer - Case of 36 y/o Pre-Menopausal Woman: Scalp Cooling Benefits, Post-Mastectomy Radiation, Which Adjuvant Hormonal Therapy Is Recommended, Long Term Adherence to AET, Fertility Preservation

FEATURING Kevin Kalinsky
  • 48 views
  • March 2, 2020
15:25

2020 Best of Breast

Decision Making in Early Stage Breast Cancer - Late Recurrence and Genomic Assay Data: Trials of TAM + Al and Extended Al & BCI Predicts Benefit from Extended Tamoxifen

FEATURING Kevin Kalinsky
  • 162 views
  • March 2, 2020
  • 1
10:26

2020 Best of Breast

Combating Endocrine Resistance in Breast Cancer: Side Effects Management & Suppression of Ovarian Function With Tamoxifen Significantly Improves DFS

FEATURING Reshma L. Mahtani
  • 24 views
  • March 2, 2020
12:07

2020 Best of Breast

Treatment of 52 y/o Post-Menopausal Woman HER2- Breast Cancer & Bone Mets: Clinical Significance of Loco-Regional Recurrence & Data on Stereotactic Ablative Radiotherapy

FEATURING Reshma L. Mahtani, Laura Freedman, Ruta Rao, Terry Mamounas
  • 24 views
  • March 2, 2020
15:10

2020 Best of Breast

Discussion on Systemic Treatment Algorithm for HR+, HER2- Recurrent Breast Cancer: Review of Approved CDK4/6 Inhibitors and Related Trials, Differences in Dosing and Safety & Managing Side Effects

FEATURING Reshma L. Mahtani, Ruta Rao, Kevin Kalinsky, Shirley Godbold
  • 58 views
  • March 2, 2020
13:39

2020 Best of Breast

Treatment of Post-Menopausal Woman in the 2nd Line Setting After Progression on CDK4/6 and AI: Data on Alpelisib + Fulvestrant and Other Treatment Options & PARP Inhibitors for gBRCA Mutated BC

FEATURING Reshma L. Mahtani
  • 482 views
  • March 2, 2020
  • 3
13:25

2020 Best of Breast

Treatment of 57 y/o Post-Menopausal Woman With HER2+ Breast Cancer: Repeating HER2 Testing on Surgical Specimen & Data on HER2 ISH Testing Using a Dual-Probe Assay

FEATURING Reshma L. Mahtani, Kristina Mirabeau-Beale, Sunil Badve, Jane Meisel, Jorge Flores
  • 212 views
  • March 2, 2020
  • 2
14:48

2020 Best of Breast

Treatment of 57 y/o Post-Menopausal Woman With HER2+ Breast Cancer - Options for Early Stage Disease: Discussing Data on Paclitaxel/Trastuzumab, T-DM1, & Pertuzumab and Trastuzumab

FEATURING Reshma L. Mahtani
  • 951 views
  • March 2, 2020
  • 4
17:17

2020 Best of Breast

Treatment of 57 y/o Post-Menopausal Woman With HER2+ Breast Cancer: Consulting Cardiologist for Asymptomatic Drops in EF During Adjuvant Trastuzumab, Radiation Considerations to Optimize Therapy & Taxane-Induced Neuropathy

FEATURING Reshma L. Mahtani
  • 14 views
  • March 2, 2020
09:36

2020 Best of Breast

Treatment of 57 y/o Post-Menopausal Woman With HER2+ Breast Cancer and Developed Brain Mets: Gamma Knife for Brain Lesions, 2nd Line Therapy With Neratinib + Xeloda & New Data on Tucatinib Show Significant Progress

FEATURING Reshma L. Mahtani
  • 38 views
  • March 2, 2020
09:07

2020 Best of Breast

Treatment of 57 y/o Post-Menopausal Woman with HER2+ Breast Cancer and Progression in Liver - Data on Durable Efficacy of Trastuzumab Deruxtecan

FEATURING Reshma L. Mahtani
  • 247 views
  • March 2, 2020
  • 1
33:37

2020 Best of Breast

Treatment Options for 55 y/o Woman With T2, Node Negative TNBC: Neoadjuvant Chemo First? Platinum or Checkpoint Inhibition + Chemo? Reviewing Data From IO Trials

FEATURING Kevin Kalinsky, Salila Kurra, Sunil Badve, Jane Meisel, Lee Schwartzberg
  • 285 views
  • March 2, 2020
  • 3
12:01

2020 Best of Breast

Treatment of 55 y/o Woman with T2, Node Negative TNBC: Checking Residual Cancer Burden Score? Considering Adjuvant Capecitabine?

FEATURING Kevin Kalinsky, Salila Kurra, Sunil Badve, Jane Meisel, Lee Schwartzberg
  • 44 views
  • March 2, 2020
13:59

2020 Best of Breast

Treatment of 55 y/o Woman with T2, Node Negative TNBC - Developing Adrenal Insufficiency After Nab-Paclitaxel + Atezolizumab, Management of Endocrinopathies & New Agents in TNBC

FEATURING Kevin Kalinsky, Salila Kurra, Sunil Badve, Jane Meisel, Lee Schwartzberg
  • 270 views
  • March 2, 2020
  • 3
25:24

2020 Best of Breast

Cardiac Oncology: Management of Cardiovascular Toxicity, Tools for the Detection and Strategies to Reduce Toxicity

FEATURING Jorge Flores
  • 14 views
  • March 2, 2020
19:43

2020 Best of Breast

Endocrinopathy Management Related to Oncologic Agents: Alpelisib and Hyperglycemia, Pembrolizumab and Hyperthyroidism

FEATURING Salila Kurra
  • 161 views
  • March 2, 2020
10:32

2020 Best of Breast

Case of 65 y/o Woman With Breast Cancer Treated With Pembro: Management of Hypothyroidism Developed After Checkpoint Inhibitor Treatment

FEATURING Salila Kurra
  • 11 views
  • March 2, 2020
20:50

2020 Best of Breast

Breast Cancer and Impact of Low Access to Innovative and Essential Medicines & High Cost Medications

FEATURING Gilberto Lopes
  • 33 views
  • March 2, 2020
  • 1
14:56

2020 Best of Breast

Cost of Developing New Drugs, Access to Innovative Cancer Drugs, & Improving Cost Effectiveness with Generics and Biosimilars

FEATURING Gilberto Lopes
  • 17 views
  • March 2, 2020